Furthermore, our results suggest that the DNMT3B rs1569686 TT genotype increased the CHD risk in the individuals with non-syndromic CHDs compared with the DS group with CHDs, which was also found under the dominant and codominant genetic models of the same polymorphism. Here, DNMT3B is linked to Dravet syndrome.